Genitourinary Radiology: Page 46

ARRS: MRI chemical analysis identifies renal cell tumors

By AuntMinnie.com staff writers

Adding chemical-shift analysis techniques to MRI exams can help differentiate conventional clear renal cell carcinoma from other types of cancer, according to a study presented Friday at the American Roentgen Ray Society (ARRS) meeting in Washington, DC.

April 18, 2013

dBMEDx raises funds

By AuntMinnie.com staff writers

Ultrasound technology developer dBMEDx has raised $1.1 million in a second round of capital financing.

April 15, 2013

ASTRO supports proton therapy for prostate cancer

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) has issued a statement supporting the use of proton beam therapy to treat prostate cancer as long as patients are enrolled in clinical trials or within prospective registries.

March 13, 2013

Apply Formula 1-type methods to smooth the way in urogenital emergencies

By Edna Astbury-Ward, PhD

VIENNA - There is no single gold standard for training medical teams, but it can pay off to adapt team-working principles from other high-reliability industries such as Formula 1 racing, and integrate them into crisis resource management training, according to a presentation by emergency room radiologists on Monday at ECR 2013.

March 10, 2013

Prepare for the transformation of care by prostate MR imaging

By Edna Astbury-Ward, PhD

VIENNA - Some urologists continue to persist with the old methods of prostate biopsy and tumor detection, despite the benefits of MRI in visualizing the most aggressive parts of prostate tumor. But the situation is changing fast, according Dr. Jelle Barentsz, PhD, of University Hospital Nijmegen in the Netherlands, in a session on Friday at ECR 2013.

March 7, 2013

Long-term prostate outcomes track PSA scores

By Cynthia E. Keen

A long-term analysis of the outcomes of prostate cancer patients who received radiation therapy showed recurrence was rare if the patient had a low prostate-specific antigen (PSA) score 15 years after treatment. The findings were published in the March issue of the Journal of Urology.

February 26, 2013

USHIFU changes name to SonaCare

By AuntMinnie.com staff writers

High-intensity focused ultrasound (HIFU) developer USHIFU announced it has changed its name to SonaCare Medical.

February 21, 2013

Bayer's radium-223 gets FDA priority review

By AuntMinnie.com staff writers

Bayer HealthCare's new drug application for its radium-223 dichloride investigational oncology compound will receive priority review by the U.S. Food and Drug Administration.

February 19, 2013

Prostate cancer patients pleased with QOL after proton therapy

By Cynthia E. Keen

More than 90% of prostate cancer patients who received proton therapy said they were satisfied with their treatment and subsequent quality of life (QOL), according to survey results presented on Wednesday at the National Proton Conference being held this week in Washington, DC.

February 12, 2013

Stereotactic radiosurgery shows promise for renal cancer

By Cynthia E. Keen

Stereotactic radiosurgery could be a useful treatment option for patients with localized primary renal cancer who do not have a prior history of pelvic or abdominal radiation, and for whom surgery is not appropriate, researchers in Ohio have concluded.

January 13, 2013

Prostate cancer CAD requires zone-specific techniques

By Erik L. Ridley

Location is everything. If recent research results are any indication, that old real-estate maxim also appears true for applying computer-aided detection (CAD) technology to the detection of prostate cancer.

January 9, 2013

SBRT halves cost vs. IMRT for prostate cancer

By Cynthia E. Keen

As members of Congress grapple over ways to reduce the U.S. budget, the publication on December 27 in the American Journal of Clinical Oncology of a complex model analyzing the costs of radiation therapy for prostate cancer seems particularly timely.

January 2, 2013

Previous Page

Page 46 of 93

Next Page